Loading stock data…
CC
$17.22-0.25 (-1.43%)
Market ClosedLast close Jul 24
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
The Chemours Company in the Basic Materials sector is trading at $17.22 with a market capitalization of $3.3B. Wall Street consensus targets $24.67 (9 analysts), implying a +43.2% move over the next 12 months. The stock is currently 40% below its 52-week high of $28.67, remaining 2.4% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +43.2% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.38B↑ | $1.33B↓ | $1.50B↓ | $1.61B↑ | $1.37B |
| Gross Profit | $212.00M↑ | $156.00M↓ | $233.00M↓ | $278.00M↑ | $236.00M |
| Operating Income | $39.00M↑ | -$5.00M↓ | $93.00M↑ | -$187.00M↓ | $78.00M |
| Net Income | -$29.00M↑ | -$61.00M↓ | $60.00M↑ | -$381.00M↓ | -$5.00M |
Peer Comparison
Fundamentals
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advan...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.30B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.57%
ROE
Average efficiency. Growth may require heavy reinvestment.
-191.16%
Volume
Today's trading volume
1.22M
Recent News
3 Stocks Worth Buying After Recent Broker Ratings Upgrade
Broker rating upgrades and robust earnings growth forecasts put PENN, CC and LITE in the spotlight as three stocks to buy now.
Should Value Investors Buy Avient (AVNT) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Wall Street Thinks Chemours Company (CC) Is Too Cheap To Ignore Now
The Chemours Company (NYSE:CC) is one of the 8 Most Undervalued Growth Stocks to Buy for the Next 10 Years. According to a report released on July 6, BMO Capital analyst John McNulty reiterated a Buy rating on The Chemours Company (NYSE:CC) with a price target of $26. The firm’s assigned price target is close […]
New York sues 3M, DuPont and other chemical companies over PFAS pollution
Investing.com -- New York Attorney General Letitia James on Thursday sued several of the nation’s largest chemical manufacturers, including 3M, DuPont, Chemours, Corteva and EIDP, alleging they knowingly caused decades of toxic PFAS contamination through consumer products while concealing the chemicals’ health and environmental risks.
3M, DuPont, Corteva, Chemours Sued by New York AG Over Toxic Pollution From Consumer Products
3M (MMM), EIDP, Chemours Co. (CC), Corteva (CTVA) and DuPont de Nemours (DD) are facing a New York S